Investigation of antimicrobial and protease-inhibitory activity from cultured cyanobacteria

References

• Andersen RA, Berges JA, Harrison PJ, Watanabe MM (2005): Recipes for freshwater and seawater media, in: Andersen RA, ed., Algal Culturing Techniques, Burlington, MA, Elsevier Academic Press, pp. 429–538.
   Google Scholar
• Andersen RA, Kawachi M (2005): Traditional microalgae isolation techniques, in: Andersen RA, ed., Algal Culturing Techniques, Burlington, MA, Elsevier Academic Press, pp. 83–100.
   Google Scholar
• Andersen RA, Morton SL, Sexton JP (1997): Provasoli-Guillard National Center for Culture of Marine Phytoplankton 1997 list of strains. J Phycol 33: S1–75.
   Web of Science ®Google Scholar
• Athamna A, Athamna M, Abu-Rashed N, Medlej B, Bast DJ, Rubinstein E (2004): Selection of Bacillus anthracis isolates resistant to antibiotics. J Antimicrob Chemother 54: 424–428.
   PubMed Web of Science ®Google Scholar
• Barretto N, Jukneliene D, Ratia K, Chen Z, Mesecar AD, Baker SC (2005): The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity. J Virol 79: 15189–15198.
   PubMed Web of Science ®Google Scholar
• Burger AM, Seth AK (2004): The ubiquitin-mediated protein degradation pathway in cancer: Therapeutic implications. Eur J Cancer 40: 2217–2229.
   PubMed Web of Science ®Google Scholar
• Chen L, Gui C, Luo X, Yang Q, Gunther S, Scandella E, Drosten C, Bai D, He X, Ludewig B, Chen J, Luo H, Yang Y, Yang Y, Zou J, Thiel V, Chen K, Shen J, Shen X, Jiang H (2005): Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro. J Virol 79: 7095–7103.
   PubMed Web of Science ®Google Scholar
• Ciechanover A (1994): The ubiquitin-proteasome proteolytic pathway. Cell 79: 13–21.
   PubMed Web of Science ®Google Scholar
• Ciechanover A, Iwai K (2004): The Ubiquitin system: From basic mechanisms to the patient bed. IUBMB Life 56: 193–201.
   PubMed Web of Science ®Google Scholar
• Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry CE, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S (1998): Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393: 537–544.
   PubMed Web of Science ®Google Scholar
• Collins L, Franzblau SG (1997): Microplate Alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob Ag Chemother 41: 1004–1009.
   PubMed Web of Science ®Google Scholar
• Davies-Coleman MT, Dzeha TM, Gray CA, Hess S, Pannell LK, Hendricks DT, Arendse CE (2003): Isolation of homodolastatin 16, a new cyclic depsipeptide from a Kenyan collection of Lyngbya majuscula. J Nat Prod 66: 712–715.
   PubMed Web of Science ®Google Scholar
• El Sayed KA, Bartyzel P, Shen XY, Perry TL, Kjawiony JK, Hamann MT (2000): Marine natural products as antituberculosis agents. Tetrahedron 56: 949–953.
   Google Scholar
• Falch BS, Konig GM, Wright AD, Sticher O, Angerhofer CK, Pezzuto JM, Bachmann H (1995): Biological-activities of cyanobacteria - Evaluation of extracts and pure compounds. Planta Med 61: 321–328.
   PubMed Web of Science ®Google Scholar
• Feling RH, Buchanan GO, Mincer TJ, Kauffman CA, Jensen PR, Fenical W (2003): Salinosporamide A: a highly cytotoxic proteasome inhibitor from a novel microbial source, a marine bacterium of the new genus Salinospora. Angew Chem Int Ed 42: 355–357.
   PubMed Web of Science ®Google Scholar
• Grum-Tokars V, Ratia K, Begaye A, Baker SC, Mesecar AD (2008): Evaluating the 3C-like protease activity of SARS-Coronavirus: Recommendations for standardized assays for drug discovery. Virus Res 133: 63–73.
   PubMed Web of Science ®Google Scholar
• Han B, McPhail KL, Ligresti A, Di Marzo V, Gerwick WH (2003): Semiplenamides A-G, fatty acid amides from a Papua New Guinea collection of the marine cyanobacterium Lyngbya semiplena. J Nat Prod 66: 1364–1368.
   PubMed Web of Science ®Google Scholar
• Harcourt BH, Jukneliene D, Kanjanahaluethai A, Bechill J, Severson KM, Smith CM, Rota PA, Baker SC (2004): Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity. J Virol 78: 13600–13612.
   PubMed Web of Science ®Google Scholar
• Harvey A (2000): Strategies for discovering drugs from previously unexplored natural products. Drug Discov Today 5: 294–300.
   PubMed Web of Science ®Google Scholar
• Hoshaw RW, Rosowski JR (1973): Methods for microscopic algae, in: JR Stein, eds., Handbook of Phycological Methods: Culture Methods & Growth Measurements, Cambridge, Cambridge University Press, pp. 53–68.
   Google Scholar
• Jaki B, Orjala J, Heilmann J, Linden A, Vogler B, Sticher O (2000): Novel extracellular diterpenoids with biological activity from the cyanobacterium Nostoc commune. J Nat Prod 63: 339–343.
   PubMed Web of Science ®Google Scholar
• Kaya K, Mahakhant A, Keovara L, Sano T, Kubo T, Takagi H (2002): Spiroidesin, a novel lipopeptide from the cyanobacterium Anabaena spiroides that inhibits cell growth of the cyanobacterium Microcystis aeruginosa. J Nat Prod 65: 920–921.
   PubMedGoogle Scholar
• Khan T, Stauffer JK, Williams R, Hixon JA, Salcedo R, Lincoln E, Back TC, Powell D, Lockett S, Arnold AC, Sayers TJ, Wigginton JM (2006): Proteasome inhibition to maximize the apoptotic potential of cytokine therapy for murine neuroblastoma tumors. J Immunol 176: 6302–6312.
   PubMed Web of Science ®Google Scholar
• King RW, Deshaies RJ, Peters JM, Kirschner MW (1996): How proteolysis drives the cell cycle. Science 274: 1652–1659.
   PubMed Web of Science ®Google Scholar
• Knight J (2001): Delivering death in the mail. Nature 414: 837–838.
   PubMedGoogle Scholar
• Komárek J, Anagnostidis K (2005): Cyanoprokaryota 2.Teil: Oscillatoriales. München, Elsevier GmbH, p. 759.
   Google Scholar
• Komárek J, Komárková J, Kling H (2003): Filamentous cyanobacteria, in: Wehr JD & Sheath RG, eds., Freshwater Algae of North America, San Diego, CA, Academic Press, pp. 117–196.
   Google Scholar
• Komárek J (2003): Coccoid and colonial cyanobacteria, in: Wehr JD & Sheath RG, eds., Freshwater Algae of North America, San Diego, CA, Academic Press, pp. 59–116.
   Google Scholar
• Liang PH (2006): Characterization and inhibition of SARS-coronavirus main protease. Curr Top Med Chem 6: 361–376.
   PubMed Web of Science ®Google Scholar
• Macmillan JB, Molinski TF (2005): Majusculoic acid, a brominated cyclopropyl fatty acid from a marine cyanobacterial mat assemblage. J Nat Prod 68: 604–606.
   PubMed Web of Science ®Google Scholar
• Metcalf JS, Lindsay J, Beattie KA, Birmingham S, Saker ML, Torokne AK, Codd GA (2002): Toxicity of cylindrospermopsin to the brine shrimp Artemia salina: Comparisons with protein synthesis inhibitors and microcystins. Toxicon 40: 1115–1120.
   PubMed Web of Science ®Google Scholar
• Meyer BN, Ferrigni NR, Putnam JE, Jacobsen LB, Nichols DE, McLaughlin JL (1982): Brine shrimp: A convenient general bioassay for active plant constituents. Planta Med 45: 31–34.
   PubMed Web of Science ®Google Scholar
• Mian P, Heilmann J, Burgi HR, Sticher O (2003): Biological screening of terrestrial and freshwater cyanobacteria for antimicrobial activity, brine shrimp lethality, and cytotoxicity. Pharm Biol 4: 243–247.
   Google Scholar
• Morens DM, Folkers GK, Fauci AS (2004): The challenge of emerging and re-emerging infectious diseases. Nature 430: 242–249.
   PubMed Web of Science ®Google Scholar
• Nogle LM, Gerwick WH (2002): Somocystinamide A, a novel cytotoxic disulfide dimer from a Fijian marine cyanobacterial mixed assemblage. Org Lett 4: 1095–1098.
   PubMed Web of Science ®Google Scholar
• Nogle LM, Gerwick WH (2003): Diverse secondary metabolites from a Puerto Rican collection of Lyngbya majuscula. J Nat Prod 66: 217–220.
   PubMedGoogle Scholar
• Ohta T, Fukuda M (2004): Ubiquitin and breast cancer. Oncogene 23: 2079–2088.
   PubMed Web of Science ®Google Scholar
• Okunade AL, Elvin-Lewis MP, Lewis WH (2004): Natural antimycobacterial metabolites: Current status. Phytochemistry 65: 1017–1032.
   PubMed Web of Science ®Google Scholar
• Ploutno A, Shoshan M, Carmeli S (2002): Three novel protease inhibitors from a natural bloom of the cyanobacterium Microcystis aeruginosa. J Nat Prod 65: 973–978.
   PubMed Web of Science ®Google Scholar
• Quintiliani R Jr, Quintiliani R (2003): Inhalational anthrax and bioterrorism. Curr Opin Pulm Med 9: 221–226.
   PubMedGoogle Scholar
• Schlösser UG (1994): SAG - Sammlung von Algenjulturen at The University of Göttingen. Catalogue of strains 1994. Bot Acta 107: 113–186.
   Google Scholar
• Starr RC, Zeikus JA (1993): UTEX - the Culture Collection of Algae at the University-Of-Texas at Austin 1993 List of Cultures. J Phycol 29: 1–106.
   Web of Science ®Google Scholar
• von Elert E, Agrawal MK, Gebauer C, Jaensch H, Bauer U, Zitt A (2004): Protease activity in gut Daphnia magna: Evidence for trypsin and chymotrypsin enzymes. Comp Biochem Phys B Comp Biochem Phys B 137: 287–296.
   PubMedGoogle Scholar
• Wetzel RG (2001): The phosphorus cycle, in: Limnology: Lake and River Ecosystems. San Diego, CA, Academic Press, pp. 239–288.
   Google Scholar
• Williams PG, Yoshida WY, Moore RE, Paul VJ (2004): Micromide and guamamide: Cytotoxic alkaloids from a species of the marine cyanobacterium Symploca. J Nat Prod 67: 49–53.
   PubMed Web of Science ®Google Scholar
• Yamaki H, Sitachitta N, Sano T, Kaya K (2005): Two new chymotrypsin inhibitors isolated from the cyanobacterium Microcystis aeruginosa NIES-88. J Nat Prod 68: 14–18.
   PubMed Web of Science ®Google Scholar